| __timestamp | TG Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 1802274 |
| Thursday, January 1, 2015 | 19886580 | 2512761 |
| Friday, January 1, 2016 | 12631689 | 2894488 |
| Sunday, January 1, 2017 | 21977998 | 8096274 |
| Monday, January 1, 2018 | 20759000 | 7985229 |
| Tuesday, January 1, 2019 | 20838000 | 8994597 |
| Wednesday, January 1, 2020 | 121812000 | 29772000 |
| Friday, January 1, 2021 | 152137000 | 33907000 |
| Saturday, January 1, 2022 | 83231000 | 26579000 |
| Sunday, January 1, 2023 | 122706000 | 49868547 |
Unleashing insights
In the competitive world of biopharmaceuticals, operational efficiency is key. This analysis of Selling, General, and Administrative (SG&A) expenses from 2014 to 2023 reveals intriguing trends for TG Therapeutics, Inc. and Verona Pharma plc. TG Therapeutics, Inc. has seen a dramatic increase in SG&A expenses, peaking in 2021 with a staggering 1.52 times the amount spent in 2014. This reflects a strategic push in their operational activities. Meanwhile, Verona Pharma plc, while maintaining a more conservative approach, has also increased its SG&A expenses by approximately 27 times over the same period, indicating a significant ramp-up in their market activities. These trends highlight the dynamic nature of the biopharma industry, where strategic investments in operational costs can be pivotal for growth and market positioning.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Selling, General, and Administrative Costs: Johnson & Johnson vs Verona Pharma plc
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Novartis AG and Verona Pharma plc
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.